• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Bacterial protein fragment kills lung cells in pulmonary fibrosis, study finds

Bioengineer by Bioengineer
March 24, 2020
in Biology
Reading Time: 4 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Image courtesy of Esteban Gabazza/Nature Communications


CHAMPAIGN, Ill. — A bacterial protein fragment instigates lung tissue death in pulmonary fibrosis, a mysterious disease affecting millions of people worldwide, according to a new study from researchers at the University of Illinois at Urbana-Champaign and Mie University in Japan.

Led by Illinois microbiology and animal sciences professor Isaac Cann and Mie University immunology professor Dr. Esteban Gabazza, the researchers published their findings in the journal Nature Communications. Cann and Gabazza are affiliates of the Carl R. Woese Institute for Genomic Biology at Illinois.

“We discovered salt-loving bacteria in the lungs of patients with pulmonary fibrosis, and these bacteria secrete a peptide that marks the lung cells it touches for death,” Cann said.

In people with pulmonary fibrosis, lung tissue becomes progressively more scarred and stiffened, with a prognosis of only three to five years of life after diagnosis. Certain environmental factors, infections or medications are linked to disease onset; however, the majority of cases are of unknown origin. These mysterious cases are called idiopathic pulmonary fibrosis. About 50,000 patients in the U.S. die of IPF every year – more than die from breast cancer, according to the IPF Foundation.

The disease progresses slowly until a point when a patient experiences a rapid worsening of breathing and loss of lung function, a phase called acute exacerbation. Yet doctors do not know what triggers acute exacerbation in a stable patient.

“More than half of the patients with IPF die because of acute exacerbation of the disease,” Gabazza said. Of those who survive an acute exacerbation event, only 50% live more than four months, he said.

Previous studies found that certain bacteria, such as strains of Halomonas, Staphylococcus and Streptococcus, proliferate in the lungs of IPF patients, likely as a result of high amounts of salt in the lining of patients’ lungs. The researchers wondered if the bacteria played a role in acute exacerbation, so they cultured bacteria associated with fibrotic lung tissue in a salty environment and studied what the bacteria secreted.

They found a small peptide, secreted by Staphylococcus nepalensis, that rapidly kills lung cells. They named the peptide corisin.

To confirm that corisin was the exacerbating culprit, Gabazza’s group ran an experiment on mice with IPF. They compared mice given corisin itself, those infected with corisin-secreting Staphylococcus nepalensis, those infected with a Staph strain that did not secrete corisin, and an untreated control group. They found that the mice given corisin or the bacterium that secretes it showed much greater signs of acute exacerbation.

They also looked at lung tissue samples from human patients and found that those who had undergone acute exacerbation had higher levels of corisin in their lungs.

Cann’s group then searched the genome of Staphylococcus nepalensis to figure out where corisin comes from. They found that it is a fragment cut from a larger protein. They tested the larger protein on lung tissue and found it did not have the destructive properties of the fragment.

“It’s like a Trojan horse,” Cann said. “Anybody trying to characterize the large protein to find what it does would never know it has this destructive element hidden inside it. The microbe makes the polypeptide and then it cuts out that small piece of it, the corisin, and that is very deadly.”

Next, the researchers hope to identify the enzyme that cuts corisin out of its larger protein. They aim to create agents to block it – effectively bolting shut the door of the Trojan horse. They also plan to identify which other strains of bacteria produce corisin or similar peptides, and to study other types of fibrosis, such as in the kidneys and liver, to see if corisin or other bacterial agents play a role in those diseases.

“Knowing that a cause of the acute exacerbation is a bacteria-derived factor gives us a fightable enemy,” Gabazza said. “On the patient side, this new discovery could mitigate the psychological stress of fighting against an ‘unknown intruder,’ while on the physician side, this can stimulate the development of strategies for treatment and drug discovery.”

###

The findings also may have important implications for the current coronavirus pandemic, as some patients may develop pulmonary fibrosis after recovering from COVID-19, in similarity to the fibrosis seen in some patients after the outbreak of the SARS coronavirus, Cann and Gabazza said.

The Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Carl R. Woese Institute for Genomic Biology and the College of Agricultural, Consumer and Environmental Sciences Office of International Programs at Illinois supported this work.

Editor’s notes: To reach Isaac Cann, call (217) 333-2090; email [email protected]. To reach Esteban Gabazza, email [email protected].

The paper “A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis” is available online. DOI: 10.1038/s41467-020-15344-3

Media Contact
Liz Ahlberg Touchstone
[email protected]
217-244-1073

Original Source

https://news.illinois.edu/view/6367/807422

Related Journal Article

http://dx.doi.org/10.1038/s41467-020-15344-3

Tags: BiologyDiagnosticsInternal MedicineMedicine/HealthMicrobiologyPulmonary/Respiratory Medicine
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

New Insights into Evolution Revealed Through Lizard Genetics

October 8, 2025
blank

Cell-Free DNA Reflects Tumor Transcription Factor Activity

October 8, 2025

New Method to Monitor Wild Reindeer Populations Could Boost Conservation Efforts

October 8, 2025

New Molecular Method Detects Varroa Destructor in Nigeria

October 8, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1054 shares
    Share 421 Tweet 263
  • New Study Reveals the Science Behind Exercise and Weight Loss

    99 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    95 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    78 shares
    Share 31 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Targeting MCL1: New Therapies for Lethal Prostate Cancer

Analyzing Methadone Levels in Post-Mortem Cases

New Vaccine Demonstrates Potential Against Typhoid and Invasive Salmonella in Initial Human Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.